Tyrosine kinase inhibitors (TKIs) are anti-cancer agents that inhibit the activity of oncogenic protein kinases. Thyroid hormone abnormalities are common during treatment with TKIs, typically manifesting as increased serum thyroid stimulating hormone concentra... ...

请注册登录后继续浏览